Results 621-640 of 1,104,474 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Cyprian Brady OR speaker:Holly Cairns OR speaker:Roderic O'Gorman OR speaker:Seán Canney OR speaker:Martin Heydon OR speaker:Aengus Ó Snodaigh OR speaker:Frank Feighan OR speaker:Mark Ward OR speaker:Aengus Ó Snodaigh08 OR speaker:Aengus Ó Snodaigh23 OR speaker:Aengus Ó Snodaigh21 OR speaker:John McGuinness OR speaker:Martin Kenny OR speaker:Ossian Smyth OR speaker:Cyprian Brady8 OR speaker:Aengus Ó Snodaigh24 OR speaker:Aengus Ó Snodaigh19 OR speaker:Dessie Ellis OR speaker:Aengus Ó Snodaigh27 OR speaker:Rose Conway-Walsh OR speaker:Chris Andrews OR speaker:Gino Kenny OR speaker:Pa Daly OR speaker:Aengus Ó Snodaigh25 OR speaker:Aengus Ó Snodaigh01 OR speaker:Aindrias Moynihan OR speaker:Niamh Smyth OR speaker:Colm Burke OR speaker:Louise O'Reilly OR speaker:Aengus Ó Snodaigh09 OR speaker:Neale Richmond)
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Did Dr. Kelly meet any barriers when speaking at the citizens' assembly? What was the feedback on the recommendations he put forward?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: Professor Comiskey said we should enable evidence-informed policy and nurse-led prescribing and she has research to support that. She said she wanted to expand on that research.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: It is anecdotal.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: It is fantastic. I thank the Chair.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Mark Ward: I was not sure what the time was, but I am fine.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Matt Shanahan: I thank the witnesses for attending. It is important to go back - the Cathaoirleach has signalled that this issue will probably be revisited - to try to understand what is the blockage to nurse prescribing. It happens in other areas of medicine, especially with the advanced clinical nurse practitioners. It is an obvious efficiency outcome and as the witnesses said, doctors may not be...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Matt Shanahan: Would any other speaker like to take that on as well?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Matt Shanahan: I want to ask both witnesses about monitoring. Dr. Kelly referenced a high level document he was not allowed to contribute to because the HSE was the lead agency evaluating all of this. What awareness do the witnesses have of the monitoring of their efficiency metrics in the system in order to understand where they are going in getting patients through the system, the waiting times and the...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I welcome our witnesses. I want to touch on stigma but before that I will go back to nurse prescribing. A lot of the discussion we are having today reminds me of when I followed the nurse prescribing journey in diabetes. It reminds me of that a lot, in that it is a lifestyle-based treatment and is very much about who you meet when you go into a clinic. At the front line that is often...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I presume we should have non-elective modules within training for all medical professionals. Would that be specifically on addiction or would it be more useful for it be about what trauma-centred care looks like?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Would the other witnesses like to come in on addiction versus trauma led?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: The research suggests that when you are on the front line, those attitudes become more prevalent.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: That would take care of all of our new cohort. There are hundreds of thousands of people working in services that are central or tangential to our health service. How do we hit all of them? Do we need to get everybody into a continuing professional development course on addiction and trauma-like care?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: How far along are we on that journey?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Working in an emergency department is different from working in a laboratory.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: I will return to the question of the inspection of services. I am a member of the Joint Committee on Health, where we talk a lot about the inspection side of things in the context of oversight, performance indicators and outcomes. Who would do that? Perhaps that is not fair. What kind of a body could the witnesses imagine undertaking that piece of work?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Could Dr. Kelly give me an idea of the breadth and level of that service? Would it include all the third-party and NGO services?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: Would it influence how drug task forces work?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: It is crazy.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (17 Oct 2024)
Neasa Hourigan: By proxy, there would be a benchmark that you could fall below and therefore-----